Bio-Technology General's BioLon
This article was originally published in The Gray Sheet
Executive Summary
Firm's 1% sodium hyaluronate viscoelastic lubricant gains FDA approval for use in ophthalmic procedures such as cataract removal to facilitate surgical manipulation of the ocular tissues. The Iselin, New Jersey company received an approvable letter in February. The product will be marketed by Akorn beginning later this year